Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A review of the potential benefits and limitations of oral glutathione supplementation.

Inflammopharmacology·2026
Same author

Nutraceuticals: A strategy to mitigate neurotoxicity.

Advances in neurotoxicology·2026
Same author

Nonantibiotic Treatment of Clinical Multidrug-Resistant Bacterial Isolates Using Chitosan Nanoparticles as a Carrier for the Supernatant of Mesenchymal Stem Cells.

The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale·2026
Same author

Green synthesis nanocomposite GO/ZnFe<sub>2</sub>O<sub>4</sub> with water extract of Teucrium polium and evaluation of its anti-bacterial and cytotoxicity activities.

Scientific reports·2026
Same author

Opioids and cancer biology: Exploring the dark side of pain relief.

Pathology, research and practice·2026
Same author

Probiotics reverse prenatal stress-induced anxiety and memory impairment in rats through gut-hippocampus axis regulation.

Brain research bulletin·2026

Related Experiment Video

Updated: Jan 2, 2026

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
08:04

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Published on: March 18, 2014

13.2K

Melatonin: an anti-tumor agent for osteosarcoma.

Hadis Fathizadeh1, Hamed Mirzaei2, Zatollah Asemi2

  • 11Department of Microbiology, Kashan University of Medical Sciences, Kashan, Islamic Republic of Iran.

Cancer Cell International
|December 5, 2019
PubMed
Summary

Melatonin, a natural hormone, shows promise as a novel therapeutic agent for osteosarcoma, a common bone cancer. Research indicates its potential as a standalone or combination treatment to improve patient outcomes.

Keywords:
MelatoninOsteosarcomaTherapy

More Related Videos

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

11.0K
A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
11:15

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

10.6K

Related Experiment Videos

Last Updated: Jan 2, 2026

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
08:04

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Published on: March 18, 2014

13.2K
Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

11.0K
A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
11:15

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

10.6K

Area of Science:

  • Oncology
  • Endocrinology
  • Biochemistry

Background:

  • Osteosarcoma is a prevalent bone cancer in children and adolescents with a high mortality rate.
  • Conventional treatments like surgery, chemotherapy, and radiotherapy have shown limited improvement in survival rates over the past three decades.
  • There is a critical need for novel and effective therapeutic strategies for osteosarcoma.

Purpose of the Study:

  • To investigate the anti-tumor effects of melatonin on osteosarcoma.
  • To explore the potential of melatonin as a new therapeutic candidate or adjuvant therapy for osteosarcoma.
  • To summarize the mechanisms of action through which melatonin exerts its anti-cancer effects in osteosarcoma.

Main Methods:

  • Review of in vitro and in vivo studies evaluating melatonin's impact on osteosarcoma and other bone cancers.
  • Analysis of melatonin's known biological activities, including its role in bone formation, immunomodulation, and antioxidant properties.

Main Results:

  • Melatonin exhibits a broad spectrum of anti-tumor activities relevant to osteosarcoma.
  • Studies suggest melatonin's deficiency may be linked to bone cancer development.
  • Evidence supports melatonin's potential as a therapeutic agent or adjunct therapy in osteosarcoma treatment.

Conclusions:

  • Melatonin demonstrates significant potential as a novel therapeutic agent for osteosarcoma.
  • Melatonin's unique properties, including its role in bone health, make it a promising candidate for cancer therapy.
  • Further research into melatonin's anti-osteosarcoma mechanisms could lead to improved treatment protocols.